Location History:
- Research Triangle Park, NC (US) (2017)
- New Castle, PA (US) (2007 - 2018)
- Hamilton, NC (US) (2020)
- Hamilton, MT (US) (2000 - 2022)
- Bigfork, MT (US) (2023)
Company Filing History:
19 out of 247 
10 out of 531 
2 out of 6 
Years Active: 2000-2023
Title: David A. Johnson: Innovator in Therapeutic Advancements
Introduction
David A. Johnson is a prolific inventor based in Hamilton, Montana, who holds an impressive portfolio of 31 patents. His work primarily focuses on the development of novel therapeutic compounds that have the potential to advance medical treatments, particularly in the field of vaccine adjuvants.
Latest Patents
Among his latest innovations, Johnson has contributed to the field with several significant patents. One of his notable inventions is related to imidazoquinoline derivatives and their use in therapy, specifically as vaccine adjuvants. This invention aims to improve the efficacy of vaccines by enhancing the immune response. Another important patent involves the phospholipidation of imidazoquinolines and oxoadenines. This invention describes a high-yielding, scalable process for the phospholipidation of these compounds, eliminating the necessity to isolate unstable intermediates. This method may have crucial applications for modifying toll-like receptor 7 (TLR7)-active and toll-like receptor 8 (TLR8)-active imidazoquinolines and oxoadenines.
Career Highlights
Throughout his career, Johnson has made significant contributions to the pharmaceutical industry, leveraging his expertise in chemistry and therapeutic development. He has had the opportunity to work with renowned companies such as Corixa Corporation and GlaxoSmithKline Biologicals SA, where he played a pivotal role in advancing research and product development.
Collaborations
Johnson's journey has been marked by collaboration with talented professionals in the field. Noteworthy colleagues include C. Gregory Sowell and Jory R. Baldridge, with whom he has shared his innovative ideas and worked on transformative projects in therapeutic research.
Conclusion
David A. Johnson stands out as a key figure in the world of innovations focusing on therapeutic advancements. With a strong emphasis on improving vaccine efficacy and developing scalable processes for pharmaceutical compounds, his contributions continue to influence research and development in healthcare. As more of his inventions come to fruition, the impact of his work will undoubtedly be felt in the future of medical therapies.